US 11224645
Glycoconjugate vaccine for leishmaniasis
granted A61KA61K2039/545A61K2039/6037
Quick answer
US patent 11224645 (Glycoconjugate vaccine for leishmaniasis) held by The Board of Regents of the University of Texas System expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/545, A61K2039/6037, A61K2039/6081, A61K39/008